Competitive intelligence reveals that companies are focusing on future development strategies, such as novel formulations and broader indications, to strengthen their positioning
Tirzepatide and additional dual GLP-1/GIP receptor agonists that could eventually be developed in the future seem to be a promising furthest advance for the management of several cardiometabolic settings
Understanding how GLP-1s work with your PCOS is so important before deciding if theyre the right fit for you
Do NOT inject quickly, because this can foam the peptide and damage it
Contrave may be a stronger match for people who deal with emotional eating, food cravings tied to reward-driven behavior, or those who also experience mood-related challenges
A clinician may review weight trend, glucose readings, blood pressure, hydration, bowel pattern, medication interactions, and lab results where appropriate